Markets:

Overview

News

Currencies

International

Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

52.03 -1.03 (-1.93%)

Streaming Delayed Price Updated: 10:50 AM EDT, Aug 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting

June 03, 2024

From Scholar Rock

Via Business Wire

Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

May 28, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity

May 22, 2024

From Scholar Rock

Via Business Wire

Scholar Rock to Participate in Upcoming Investor Conferences

May 20, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 17, 2024

From Scholar Rock

Via Business Wire

Scholar Rock to Host Investor Day on May 22, 2024

May 14, 2024

From Scholar Rock

Via Business Wire

SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q1 2024 ↗

May 07, 2024

SRRK stock results show that Scholar Rock Holding missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress

May 07, 2024

From Scholar Rock

Via Business Wire

3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains ↗

April 24, 2024

These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.

Via InvestorPlace

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 12, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst ↗

March 28, 2024

Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of key programs utilizing selective myostatin inhibition to

Via Benzinga

SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q4 2023 ↗

March 19, 2024

SRRK stock results show that Scholar Rock Holding missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress

March 19, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 15, 2024

From Scholar Rock, Inc.

Via Business Wire

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday ↗

March 05, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

Scholar Rock to Participate in Upcoming Investor Conferences

February 28, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 16, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer

February 15, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management

February 06, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia

January 25, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity

January 23, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 12, 2024

From Scholar Rock

Via Business Wire

Scholar Rock Provides Corporate Update and Highlights Priorities for 2024

January 04, 2024

From Scholar Rock, Inc.

Via Business Wire

3 Biotech Stocks at the Forefront of the Quest for Eternal Youth ↗

January 02, 2024

Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.

Via InvestorPlace

Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 19, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 15, 2023

From Scholar Rock

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 24, 2023

Via Benzinga

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress

November 07, 2023

From Scholar Rock, Inc.

Via Business Wire

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.